Company Overview of The Global Alliance for TB Drug Development
Melvin K. Spigelman M.D.
Chief Executive Officer, President and Director, The Global Alliance for TB Drug Development
|Age||Total Calculated Compensation||This person is connected to 4 Board Members in 4 different organizations across 3 different industries.|
See Board Relationships
BackgroundDr. Melvin K. Spigelman, Mel, M.D. serves as the Chief Executive Officer and President of Global Alliance for TB Drug Development. Dr. Spigelman has been at Global Alliance for TB Drug Development since January 2009 and also serves as a Director. Previously, Dr. Spigelman served as a Research and Development Director since 2003. He also serves as a Venture Partner at Wellington Partners Venture Capital GmbH. Dr. Spigelman joined Wellington Partners Venture Capital GmbH ...
--, -- --
Board Members Memberships
Chief Executive Officer, President and Director
Director and Member of Nominating & Corporate Governance Committee
Director, Member of Compensation Committee, Member of Audit Committee and Member of Special Project Committee
Mount Sinai School Of Medicine
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
Total CompensationThere is no Total Compensation data available.
|There is no Competitor Compensation data available.|